Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Matthew Perrone

Alzheimer's drug that modestly slows disease OK'd by FDA

AP2003

An experimental Alzheimer’s disease drug that appears to slow down cognitive decline has been given fast-track approval by the US Food and Drug Administration.

The approval on Friday comes after clinical trial results published last November indicated that the drug, lecanemab, successfully slows cognitive decline in people with mild impairment from the disease.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.